MedPath
HSA Approval

MIOCHOL-E INTRAOCULAR SOLUTION

SIN09252P

MIOCHOL-E INTRAOCULAR SOLUTION

MIOCHOL-E INTRAOCULAR SOLUTION

March 18, 1997

BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAOCULAR

Medical Information

S01EB09

acetylcholine

Manufacturer Information

BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED

Novartis Pharma Stein AG

Active Ingredients

ACETYLCHOLINE CHLORIDE

20 mg/2 ml

Acetylcholine

Documents

Package Inserts

Miochol-E Intraocular Solution PI.pdf

Approved: July 10, 2012

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MIOCHOL-E INTRAOCULAR SOLUTION - HSA Approval | MedPath